Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000895421-25-000471·MORGAN STANLEY
Schedule 13G ownership disclosure
UROGEN PHARMA LTD
Ordinary Shares · CUSIP: M96088105
Event date: 2025-06-30
- Filing-level shares
- 2,488,299
- Percent of class
- 5.4%
- Morgan Stanley
Shares: 2,488,299 · Class: 5.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000895421-25-000471
- Form type
- SCHEDULE 13G
- Filer
- MORGAN STANLEY
- CIK
- CIK 895421
- Filed
- Aug 06, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership